United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60760-694_5450def0-8bbc-48af-e063-6294a90a46b0
- Product NDC
- 60760-694
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- St. Mary's Medical Park Pharmacy
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211028
- Source listing expiry
- 20271231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET in 1 BOTTLE, PLASTIC (60760-694-04) · 60760-694-04
- 15 TABLET in 1 BOTTLE, PLASTIC (60760-694-15) · 60760-694-15
- 30 TABLET in 1 BOTTLE, PLASTIC (60760-694-30) · 60760-694-30
- 60 TABLET in 1 BOTTLE, PLASTIC (60760-694-60) · 60760-694-60
- 90 TABLET in 1 BOTTLE, PLASTIC (60760-694-90) · 60760-694-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →